Published in Nat Cell Biol on August 01, 2002
Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development (2003) 4.31
Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res (2009) 3.66
Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol (2008) 3.62
Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discov (2011) 3.26
The CCN family of proteins: structure-function relationships. Trends Biochem Sci (2008) 2.82
Matricellular proteins in cardiac adaptation and disease. Physiol Rev (2012) 2.01
Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ Res (2010) 1.94
Reduced expression of connective tissue growth factor (CTGF/CCN2) mediates collagen loss in chronologically aged human skin. J Invest Dermatol (2009) 1.93
The proximal tubule in the pathophysiology of the diabetic kidney. Am J Physiol Regul Integr Comp Physiol (2011) 1.84
BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation. Mol Cell Biol (2003) 1.83
CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol Biol Cell (2004) 1.83
Generation of the primary hair follicle pattern. Proc Natl Acad Sci U S A (2006) 1.72
The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth. Cancer Res (2009) 1.64
SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system. Mol Biol Cell (2003) 1.63
Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene. BMC Dev Biol (2008) 1.62
Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease. Fibrogenesis Tissue Repair (2011) 1.61
Gene expression profiling reveals novel TGFbeta targets in adult lung fibroblasts. Respir Res (2004) 1.55
Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1. Cardiovasc Res (2013) 1.55
CCN family 2/connective tissue growth factor modulates BMP signalling as a signal conductor, which action regulates the proliferation and differentiation of chondrocytes. J Biochem (2008) 1.55
Circulating bone morphogenetic protein 1-3 isoform increases renal fibrosis. J Am Soc Nephrol (2011) 1.53
WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair. Am J Pathol (2004) 1.53
Kielin/chordin-like protein attenuates both acute and chronic renal injury. J Am Soc Nephrol (2013) 1.51
CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. Fibrogenesis Tissue Repair (2012) 1.49
Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. Vasc Health Risk Manag (2008) 1.49
Angiotensin II-mediated up-regulation of connective tissue growth factor promotes atrial tissue fibrosis in the canine atrial fibrillation model. Europace (2012) 1.45
Report on the second international workshop on the CCN family of genes. Mol Pathol (2003) 1.45
The matricellular protein CCN1 is essential for cardiac development. Circ Res (2006) 1.41
Microarray identifies extensive downregulation of noncollagen extracellular matrix and profibrotic growth factor genes in chronic isolated mitral regurgitation in the dog. Circulation (2009) 1.39
Smad3-dependent CCN2 mediates fibronectin expression in human skin dermal fibroblasts. PLoS One (2017) 1.39
Nell-1-induced bone regeneration in calvarial defects. Am J Pathol (2006) 1.38
Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. Bone (2012) 1.38
Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it? J Cell Commun Signal (2009) 1.33
Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo. J Cell Commun Signal (2009) 1.33
CCN2/connective tissue growth factor is essential for pericyte adhesion and endothelial basement membrane formation during angiogenesis. PLoS One (2012) 1.33
Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria. Clin J Am Soc Nephrol (2010) 1.30
Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis. Am J Respir Crit Care Med (2007) 1.29
Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes. Hepatology (2009) 1.28
The pro-BMP activity of Twisted gastrulation is independent of BMP binding. Development (2003) 1.25
Connective tissue growth factor (CTGF) inactivation leads to defects in islet cell lineage allocation and beta-cell proliferation during embryogenesis. Mol Endocrinol (2009) 1.24
CCN2 (Connective Tissue Growth Factor) is essential for extracellular matrix production and integrin signaling in chondrocytes. J Cell Commun Signal (2007) 1.24
TAF4 inactivation in embryonic fibroblasts activates TGF beta signalling and autocrine growth. EMBO J (2005) 1.23
WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity. J Bone Miner Res (2011) 1.23
CCN6 modulates BMP signaling via the Smad-independent TAK1/p38 pathway, acting to suppress metastasis of breast cancer. Cancer Res (2012) 1.22
Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options. Comp Hepatol (2007) 1.22
The CCN family member Wisp3, mutant in progressive pseudorheumatoid dysplasia, modulates BMP and Wnt signaling. J Clin Invest (2007) 1.19
CTGF inhibits BMP-7 signaling in diabetic nephropathy. J Am Soc Nephrol (2008) 1.19
Mammalian twisted gastrulation is essential for skeleto-lymphogenesis. Mol Cell Biol (2003) 1.17
Smad signaling in skeletal development and regeneration. Cytokine Growth Factor Rev (2009) 1.17
MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor. PLoS One (2013) 1.15
Characterization of wise protein and its molecular mechanism to interact with both Wnt and BMP signals. J Biol Chem (2009) 1.14
Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation. Cell Commun Signal (2005) 1.12
WISP1, a pro-mitogenic, pro-survival factor, mediates tumor necrosis factor-alpha (TNF-alpha)-stimulated cardiac fibroblast proliferation but inhibits TNF-alpha-induced cardiomyocyte death. J Biol Chem (2009) 1.12
The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis. Crit Rev Eukaryot Gene Expr (2011) 1.11
Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring. Am J Pathol (2003) 1.11
Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis. Biochim Biophys Acta (2013) 1.11
Regulation of CCN2/connective tissue growth factor expression in the nucleus pulposus of the intervertebral disc: role of Smad and activator protein 1 signaling. Arthritis Rheum (2010) 1.11
The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis. Histol Histopathol (2010) 1.11
A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2006) 1.10
Disruption of LTBP-4 function reduces TGF-beta activation and enhances BMP-4 signaling in the lung. J Cell Biol (2004) 1.09
CCN2 is required for the TGF-β induced activation of Smad1-Erk1/2 signaling network. PLoS One (2011) 1.09
Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia. Endocrinology (2008) 1.08
Comparative spatial and temporal localisation of perlecan, aggrecan and type I, II and IV collagen in the ovine meniscus: an ageing study. Histochem Cell Biol (2005) 1.08
Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis. Int J Oncol (2011) 1.07
Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms. Cardiovasc Res (2010) 1.07
Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II. PLoS One (2013) 1.06
Roles for CCN2 in normal physiological processes. Cell Mol Life Sci (2011) 1.06
Molecular targets for treatment of kidney fibrosis. J Mol Med (Berl) (2012) 1.06
Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts. BMC Musculoskelet Disord (2011) 1.06
Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: implication in radiation-induced vascular damages. Am J Pathol (2006) 1.05
Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy. Int J Exp Pathol (2010) 1.05
O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation. Dev Biol (2010) 1.05
Focal adhesion kinase/Src suppresses early chondrogenesis: central role of CCN2. J Biol Chem (2008) 1.04
The mechanism of TGF-β signaling during palate development. Oral Dis (2011) 1.04
Loss of endogenous bone morphogenetic protein-6 aggravates renal fibrosis. Am J Pathol (2011) 1.03
Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer. Front Physiol (2013) 1.03
Noncanonical transforming growth factor beta signaling in scleroderma fibrosis. Curr Opin Rheumatol (2009) 1.03
TGF-beta1 and WISP-1/CCN-4 can regulate each other's activity to cooperatively control osteoblast function. J Cell Biochem (2008) 1.03
Connective tissue growth factor is required for skeletal development and postnatal skeletal homeostasis in male mice. Endocrinology (2010) 1.02
Connective tissue growth factor enhances osteoblastogenesis in vitro. J Biol Chem (2008) 1.02
Conditional inactivation of noggin in the postnatal skeleton causes osteopenia. Endocrinology (2012) 1.01
Connective tissue growth factor/CCN2-null mouse embryonic fibroblasts retain intact transforming growth factor-beta responsiveness. Exp Cell Res (2007) 0.99
Recent advances in annular pathobiology provide insights into rim-lesion mediated intervertebral disc degeneration and potential new approaches to annular repair strategies. Eur Spine J (2008) 0.99
Expression profiling and comparative genomics identify a conserved regulatory region controlling midline expression in the zebrafish embryo. Genome Res (2004) 0.98
CTGF disrupts alveolarization and induces pulmonary hypertension in neonatal mice: implication in the pathogenesis of severe bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol (2011) 0.97
Mechanical strain activates a program of genes functionally involved in paracrine signaling of angiogenesis. Physiol Genomics (2008) 0.97
Nephroblastoma overexpressed (Nov) inactivation sensitizes osteoblasts to bone morphogenetic protein-2, but nov is dispensable for skeletal homeostasis. Endocrinology (2009) 0.97
The CCN family proteins: modulators of bone development and novel targets in bone-associated tumors. Biomed Res Int (2014) 0.97
LRP1 protects the vasculature by regulating levels of connective tissue growth factor and HtrA1. Arterioscler Thromb Vasc Biol (2013) 0.96
Decorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activity. J Biol Chem (2011) 0.96
Management of fibrosis: the mesenchymal stromal cells breakthrough. Stem Cells Int (2014) 0.96
Activation of TGF-beta within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factor. J Cell Mol Med (2008) 0.96
Soluble repulsive guidance molecule c/hemojuvelin is a broad spectrum bone morphogenetic protein (BMP) antagonist and inhibits both BMP2- and BMP6-mediated signaling and gene expression. J Biol Chem (2010) 0.96
CCN2: a master regulator of the genesis of bone and cartilage. J Cell Commun Signal (2013) 0.96
The role of CCN2 in cartilage and bone development. J Cell Commun Signal (2011) 0.96
Targeting of TGFβ signature and its essential component CTGF by miR-18 correlates with improved survival in glioblastoma. RNA (2012) 0.95
The cysteine-rich domain protein KCP is a suppressor of transforming growth factor beta/activin signaling in renal epithelia. Mol Cell Biol (2006) 0.95
Loss of HNF6 expression correlates with human pancreatic cancer progression. Lab Invest (2014) 0.95
Autophagy fosters myofibroblast differentiation through MTORC2 activation and downstream upregulation of CTGF. Autophagy (2014) 0.95
International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. Pharmacol Rev (2015) 0.94
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A (1986) 12.14
TGF beta signals through a heteromeric protein kinase receptor complex. Cell (1992) 8.12
Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell (1992) 5.31
Xenopus chordin: a novel dorsalizing factor activated by organizer-specific homeobox genes. Cell (1994) 4.53
The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett (1993) 3.99
Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell (1996) 3.91
CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem (2001) 3.28
A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ (1996) 3.05
The L45 loop in type I receptors for TGF-beta family members is a critical determinant in specifying Smad isoform activation. FEBS Lett (1998) 3.00
Connective tissue growth factor: what's in a name? Mol Genet Metab (2000) 2.82
Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J (2001) 2.79
Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol (1996) 2.70
Type IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGF-beta1 and BMP-2. J Cell Biol (1999) 2.17
BMP-binding modules in chordin: a model for signalling regulation in the extracellular space. Development (2000) 2.02
A mouse cerberus/Dan-related gene family. Dev Biol (1999) 1.97
Chordin-like CR domains and the regulation of evolutionarily conserved extracellular signaling systems. Gene (2002) 1.88
Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci U S A (1997) 1.88
Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. Exp Cell Res (1997) 1.88
The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun (1990) 1.88
Proteolytic cleavage of Chordin as a switch for the dual activities of Twisted gastrulation in BMP signaling. Development (2001) 1.86
The thrombospondin type 1 repeat (TSR) superfamily: diverse proteins with related roles in neuronal development. Dev Dyn (2000) 1.86
Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci U S A (1998) 1.86
The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor. J Biol Chem (2001) 1.73
Identification of receptors for type-beta transforming growth factor. Methods Enzymol (1987) 1.72
Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. Cell Growth Differ (1997) 1.40
von Willebrand factor shares a distinctive cysteine-rich domain with thrombospondin and procollagen. Biochem Biophys Res Commun (1987) 1.38
Ventroptin: a BMP-4 antagonist expressed in a double-gradient pattern in the retina. Science (2001) 1.36
Inner cell mass-specific expression of a cell adhesion molecule (PECAM-1/CD31) in the mouse blastocyst. Dev Biol (2001) 1.27
A novel chordin-like protein inhibitor for bone morphogenetic proteins expressed preferentially in mesenchymal cell lineages. Dev Biol (2001) 1.19
Use of monoclonal antibody to detect bone morphogenetic protein-4 (BMP-4). Bone (1995) 1.00
Nuclear segregation of U2 snRNA requires binding of specific snRNP proteins. Cell (1985) 4.98
Xenopus chordin: a novel dorsalizing factor activated by organizer-specific homeobox genes. Cell (1994) 4.53
Fly and frog homoeo domains show homologies with yeast mating type regulatory proteins. Nature (1984) 4.33
Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell (1996) 3.91
An enhancer-like sequence within the Xenopus U2 gene promoter facilitates the formation of stable transcription complexes. Nature (1985) 3.80
Assembly in vitro of nuclei active in nuclear protein transport: ATP is required for nucleoplasmin accumulation. EMBO J (1986) 3.60
The nuclear migration signal of Xenopus laevis nucleoplasmin. EMBO J (1987) 3.36
Intracellular transport of microinjected 5S and small nuclear RNAs. Nature (1982) 3.28
Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell (1997) 3.23
Molecular nature of Spemann's organizer: the role of the Xenopus homeobox gene goosecoid. Cell (1991) 3.23
The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals. Nature (1999) 3.19
Order and intracellular location of the events involved in the maturation of a spliced tRNA. Nature (1980) 3.07
Nucleocytoplasmic segregation of proteins and RNAs. Cell (1983) 3.03
Regulation of ADMP and BMP2/4/7 at opposite embryonic poles generates a self-regulating morphogenetic field. Cell (2005) 2.96
Intracellular migration of nuclear proteins in Xenopus oocytes. Nature (1978) 2.91
Embryonic dorsal-ventral signaling: secreted frizzled-related proteins as inhibitors of tolloid proteinases. Cell (2006) 2.85
Cerberus-like is a secreted factor with neutralizing activity expressed in the anterior primitive endoderm of the mouse gastrula. Mech Dev (1997) 2.83
The evolutionarily conserved BMP-binding protein Twisted gastrulation promotes BMP signalling. Nature (2000) 2.82
The organizer factors Chordin and Noggin are required for mouse forebrain development. Nature (2000) 2.78
Regulation of neural induction by the Chd and Bmp-4 antagonistic patterning signals in Xenopus. Nature (1995) 2.75
A conserved system for dorsal-ventral patterning in insects and vertebrates involving sog and chordin. Nature (1995) 2.58
Nucleocytoplasmic distribution of snRNPs and stockpiled snRNA-binding proteins during oogenesis and early development in Xenopus laevis. Cell (1983) 2.57
RNA processing in microinjected Xenopus oocytes. Sequential addition of base modifications in the spliced transfer RNA. J Mol Biol (1981) 2.55
Cerberus is a head-inducing secreted factor expressed in the anterior endoderm of Spemann's organizer. Nature (1996) 2.54
Molecular characterization of ribonucleoprotein antigens bound by antinuclear antibodies. A diagnostic evaluation. Arthritis Rheum (1982) 2.45
Cleavage of Chordin by Xolloid metalloprotease suggests a role for proteolytic processing in the regulation of Spemann organizer activity. Cell (1997) 2.44
Transcription and processing of cloned yeast tyrosine tRNA genes microinjected into frog oocytes. Nature (1979) 2.30
An acidic protein which assembles nucleosomes in vitro is the most abundant protein in Xenopus oocyte nuclei. J Mol Biol (1980) 2.25
Xenopus laevis U1 snRNA genes: characterisation of transcriptionally active genes reveals major and minor repeated gene families. EMBO J (1984) 2.08
Cloning of an X. laevis gene expressed during early embryogenesis coding for a peptide region homologous to Drosophila homeotic genes. Cell (1984) 2.08
BMP-binding modules in chordin: a model for signalling regulation in the extracellular space. Development (2000) 2.02
Endodermal Nodal-related signals and mesoderm induction in Xenopus. Development (2000) 1.97
Asymmetric mitosis: Unequal segregation of proteins destined for degradation. Proc Natl Acad Sci U S A (2008) 1.94
Organizer-specific homeobox genes in Xenopus laevis embryos. Science (1991) 1.90
Chordin-like CR domains and the regulation of evolutionarily conserved extracellular signaling systems. Gene (2002) 1.88
Proteolytic cleavage of Chordin as a switch for the dual activities of Twisted gastrulation in BMP signaling. Development (2001) 1.86
Gastrulation in the mouse: the role of the homeobox gene goosecoid. Cell (1992) 1.83
Ectodermal patterning in vertebrate embryos. Dev Biol (1997) 1.81
Coupled transcription-translation of DNA injected into Xenopus oocytes. Cell (1977) 1.78
Crossveinless-2 Is a BMP feedback inhibitor that binds Chordin/BMP to regulate Xenopus embryonic patterning. Dev Cell (2008) 1.69
Chordin is required for the Spemann organizer transplantation phenomenon in Xenopus embryos. Dev Cell (2003) 1.68
Genetic analysis of the processing of a spliced tRNA. EMBO J (1982) 1.67
On the function of BMP-4 in patterning the marginal zone of the Xenopus embryo. EMBO J (1994) 1.67
The Xenopus dorsalizing factor noggin ventralizes Drosophila embryos by preventing DPP from activating its receptor. Cell (1996) 1.64
Consanguineous marriages, pearls and perils: Geneva International Consanguinity Workshop Report. Genet Med (2011) 1.62
Neural and head induction by insulin-like growth factor signals. Dev Cell (2001) 1.60
A homeobox-containing marker of posterior neural differentiation shows the importance of predetermination in neural induction. Cell (1987) 1.58
Activity-induced protocadherin arcadlin regulates dendritic spine number by triggering N-cadherin endocytosis via TAO2beta and p38 MAP kinases. Neuron (2007) 1.58
Homeotic transformations in the mouse induced by overexpression of a human Hox3.3 transgene. Cell (1992) 1.58
Expression of zebrafish goosecoid and no tail gene products in wild-type and mutant no tail embryos. Development (1994) 1.57
Small nuclear U-ribonucleoproteins in Xenopus laevis development. Uncoupled accumulation of the protein and RNA components. J Mol Biol (1984) 1.56
Targeted mutation of the murine goosecoid gene results in craniofacial defects and neonatal death. Development (1995) 1.55
Differential utilization of the same reading frame in a Xenopus homeobox gene encodes two related proteins sharing the same DNA-binding specificity. EMBO J (1988) 1.54
Neural induction in Xenopus: requirement for ectodermal and endomesodermal signals via Chordin, Noggin, beta-Catenin, and Cerberus. PLoS Biol (2004) 1.52
Vertebrate homeodomain proteins: families of region-specific transcription factors. Trends Biochem Sci (1989) 1.52
Default neural induction: neuralization of dissociated Xenopus cells is mediated by Ras/MAPK activation. Genes Dev (2005) 1.52
Zebrafish paraxial protocadherin is a downstream target of spadetail involved in morphogenesis of gastrula mesoderm. Development (1998) 1.48
A Xenopus laevis gene encodes both homeobox-containing and homeobox-less transcripts. EMBO J (1987) 1.42
The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity. Development (2010) 1.41
Cell adhesion molecules as targets for Hox genes: neural cell adhesion molecule promoter activity is modulated by cotransfection with Hox-2.5 and -2.4. Proc Natl Acad Sci U S A (1992) 1.39
Endoderm induction by the organizer-secreted factors chordin and noggin in Xenopus animal caps. EMBO J (1996) 1.39
Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1. Nat Genet (2011) 1.39
Intranuclear location of the tRNA splicing enzymes. Cell (1981) 1.39
Injected nuclei in frog oocytes:RNA synthesis and protein exchange. J Embryol Exp Morphol (1976) 1.37
Multiple retinoid-responsive receptors in a single cell: families of retinoid "X" receptors and retinoic acid receptors in the Xenopus egg. Proc Natl Acad Sci U S A (1992) 1.34
The role of chordin/Bmp signals in mammalian pharyngeal development and DiGeorge syndrome. Development (2003) 1.29
The homeobox gene goosecoid controls cell migration in Xenopus embryos. Cell (1993) 1.29
The pro-BMP activity of Twisted gastrulation is independent of BMP binding. Development (2003) 1.25
XlHbox 8: a novel Xenopus homeo protein restricted to a narrow band of endoderm. Development (1989) 1.25
Loss of CHSY1, a secreted FRINGE enzyme, causes syndromic brachydactyly in humans via increased NOTCH signaling. Am J Hum Genet (2010) 1.24
C5orf42 is the major gene responsible for OFD syndrome type VI. Hum Genet (2013) 1.24
Mesodermal patterning by a gradient of the vertebrate homeobox gene goosecoid. Science (1994) 1.21
The protocadherin PAPC establishes segmental boundaries during somitogenesis in xenopus embryos. Curr Biol (2000) 1.21
Cerberus-like is a secreted BMP and nodal antagonist not essential for mouse development. Genesis (2000) 1.20
Differential activation of Xenopus homeo box genes by mesoderm-inducing growth factors and retinoic acid. Genes Dev (1990) 1.20
A direct screen for secreted proteins in Xenopus embryos identifies distinct activities for the Wnt antagonists Crescent and Frzb-1. Mech Dev (2000) 1.19
Integrating positional information at the level of Smad1/5/8. Curr Opin Genet Dev (2008) 1.17
Neural induction in the absence of mesoderm: beta-catenin-dependent expression of secreted BMP antagonists at the blastula stage in Xenopus. Dev Biol (2001) 1.16
Cloning of nucleoplasmin from Xenopus laevis oocytes and analysis of its developmental expression. Genes Dev (1987) 1.16
Injected nuclei in frog oocytes provide a living cell system for the study of transcriptional control. Nature (1976) 1.16
Binding and transcriptional activation of the promoter for the neural cell adhesion molecule by HoxC6 (Hox-3.3). Proc Natl Acad Sci U S A (1993) 1.16
Development of the vertebral morphogenetic field in the mouse: interactions between Crossveinless-2 and Twisted Gastrulation. Dev Biol (2008) 1.15
The homeobox gene goosecoid and the origin of organizer cells in the early chick blastoderm. Cell (1993) 1.14
Interference with function of a homeobox gene in Xenopus embryos produces malformations of the anterior spinal cord. Cell (1989) 1.14
42S p48--the most abundant protein in previtellogenic Xenopus oocytes--resembles elongation factor 1 alpha structurally and functionally. EMBO J (1987) 1.13
Duplicated homeobox genes in Xenopus. Dev Biol (1989) 1.12
Complementary homeo protein gradients in developing limb buds. Genes Dev (1989) 1.11
The Xenopus XIHbox 6 homeo protein, a marker of posterior neural induction, is expressed in proliferating neurons. Development (1990) 1.11
BXR, an embryonic orphan nuclear receptor activated by a novel class of endogenous benzoate metabolites. Genes Dev (1998) 1.10
Gene activation in somatic nuclei after injection into amphibian oocytes. Proc Natl Acad Sci U S A (1977) 1.10
Xenopus axis formation: induction of goosecoid by injected Xwnt-8 and activin mRNAs. Development (1993) 1.10
The opposing homeobox genes Goosecoid and Vent1/2 self-regulate Xenopus patterning. EMBO J (2007) 1.09
Gradients of homeoproteins in developing feather buds. Development (1990) 1.09
Inactivation of mouse Twisted gastrulation reveals its role in promoting Bmp4 activity during forebrain development. Development (2003) 1.09
Haploinsufficiency for AAGAB causes clinically heterogeneous forms of punctate palmoplantar keratoderma. Nat Genet (2012) 1.08